{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:08:41Z","timestamp":1789204121364,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.drugalcdep.2008.01.007","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T19:48:41Z","timestamp":1204919321000},"page":"147-151","source":"Crossref","is-referenced-by-count":11,"title":["Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice"],"prefix":"10.1016","volume":"95","author":[{"given":"Adam","family":"Bisaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"W\u00f3jcikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wladyslawa Anna","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Popik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.drugalcdep.2008.01.007_bib1","doi-asserted-by":"crossref","DOI":"10.1080\/10550490802019543","article-title":"Dextromethorphan\/Quinidine for opioid Detoxification","volume":"17","author":"Akerele","year":"2008","journal-title":"Am. J. Addictions"},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00002826-199212000-00009","article-title":"Tolerability of oral dextromethorphan in patients with a history of brain ischemia","volume":"15","author":"Albers","year":"1992","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2165\/00002018-199207030-00004","article-title":"Dextromethorphan: an overview of safety issues","volume":"7","author":"Bem","year":"1992","journal-title":"Drug Saf."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.0306-5251.2001.01548.x","article-title":"Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs","volume":"53","author":"Bertilsson","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(99)00107-6","article-title":"In search of a new pharmacological treatment of drug addiction: N-methyl-d-aspartate (NMDA) antagonists","volume":"59","author":"Bisaga","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1176\/ajp.154.4.584a","article-title":"Opiate withdrawal using dextromethorphan","volume":"154","author":"Bisaga","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-4347(01)00555-2","article-title":"Semi-automated liquid\u2013liquid back-extraction in a 96-well format to decrease sample preparation time for the determination of dextromethorphan and dextrorphan in human plasma","volume":"772","author":"Bolden","year":"2002","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0009-9236(96)90056-9","article-title":"The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans","volume":"60","author":"Capon","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib9","first-page":"1130","article-title":"In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse","volume":"25","author":"Chauret","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1472-8206.1998.tb00982.x","article-title":"Dextromethorphan and dextrorphan in rats: common antitussives\u2014different behavioural profiles","volume":"12","author":"Dematteis","year":"1998","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(99)00396-9","article-title":"Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice","volume":"377","author":"Farzin","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib12","first-page":"524","article-title":"Actions and addiction liabilities of dromoran derivatives in man","volume":"107","author":"Isbell","year":"1953","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib13","series-title":"The Abstracts Band of the First European Symposium on Drug Addiction and AIDS","first-page":"320","article-title":"The treatment with dextromethorphan of heroin addicts on ambulatory basis","author":"Koyuncuoglu","year":"1991"},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib14","first-page":"13","article-title":"The combination of tizanidine markedly improves the treatment with dextromethorphan of heroin addicted outpatients","volume":"33","author":"Koyuncuoglu","year":"1995","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib15","first-page":"147","article-title":"The treatment of heroin addicts with dextromethorphan: a double-blind comparison of dextromethorphan with chloropromazine","volume":"28","author":"Koyuncuoglu","year":"1990","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0091-3057(90)90366-P","article-title":"Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats","volume":"35","author":"Koyuncuoglu","year":"1990","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00213-005-0182-5","article-title":"2-MPPA, a selective glutamate synthesis inhibitor, inhibits morphine tolerance but not dependence in C57\/Bl mice","volume":"183","author":"Kozela","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.pharmtox.41.1.569","article-title":"Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations","volume":"53","author":"Lee","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib19","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/jps.20884","article-title":"In vitro assessment of cytochrome P450 inhibition: strategies for increasing LC\/MS-based assay throughput using a one-point IC(50) method and multiplexing high-performance liquid chromatography","volume":"96","author":"Lin","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0304-3959(96)81972-5","article-title":"Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance","volume":"67","author":"Manning","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2885.2004.00559.x","article-title":"Influence of concomitant quinidine administration on dextromethorphan disposition in rats","volume":"27","author":"Marier","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib22","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.lfs.2005.04.025","article-title":"Enhancing the uptake of dextromethorphan in the CNS of rats by concomitant administration of the P-gp inhibitor verapamil","volume":"77","author":"Marier","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","article-title":"Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance","volume":"75","author":"Marzolini","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib24","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0022-3565(24)36943-5","article-title":"Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes","volume":"282","author":"Masubuchi","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/13556210500352410","article-title":"Dextromethorphan psychosis, dependence and physical withdrawal","volume":"10","author":"Miller","year":"2005","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib26","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0028-3908(95)00092-K","article-title":"Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo","volume":"34","author":"Parsons","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib27","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/0091270004269521","article-title":"Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers","volume":"44","author":"Pope","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(96)00249-X","article-title":"A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal","volume":"307","author":"Rosen","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00004714-199508000-00005","article-title":"Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition","volume":"15","author":"Schadel","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/0269881104047278","article-title":"P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6","volume":"18","author":"Uhr","year":"2004","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2008.01.007_bib31","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1124\/dmd.105.008870","article-title":"Expression, purification, and characterization of mouse CYP2d22","volume":"34","author":"Yu","year":"2006","journal-title":"Drug Metab. Dispos."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871608000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871608000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:27:25Z","timestamp":1738110445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871608000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0376871608000276"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2008.01.007","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}